Regeneron and Sanofi Announce FDA Approval of Dupixent for Treatment of Bullous Pemphigoid in Adults
20/6 07:10
FDA approves Dupixent for treating bullous pemphigoid in adults, showing significant improvements in disease management....
|
|
|
20/6 07:10
FDA approves Dupixent for treating bullous pemphigoid in adults, showing significant improvements in disease management....